Selected research
Industry Growth & Trends
Global Pet Intestinal Medicine Industry Growth and Trends Forecast to 2032
Market perspective
The global Pet Intestinal Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Intestinal Medicine include Boehringer Ingelheim, CAHIC, Ceva, Dechra Veterinary Products, Elanco, Jindun, Norbrook, Ouro Fino Saude and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pet Intestinal Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pet Intestinal Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Intestinal Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Intestinal Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pet Intestinal Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pet Intestinal Medicine Market by Company
Boehringer Ingelheim
CAHIC
Ceva
Dechra Veterinary Products
Elanco
Jindun
Norbrook
Ouro Fino Saude
Vetoquinol
Virbac
Wuhan chopperlvya
Merck
Zoetis
Pet Intestinal Medicine Segment by Type
Powder
Liquid
Pet Intestinal Medicine Segment by Application
Reptile
Cat
Dog
Other
Pet Intestinal Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Intestinal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Intestinal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Intestinal Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pet Intestinal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Liquid
Applications
- Reptile
- Cat
- Dog
- Other
Companies covered
- Boehringer Ingelheim
- CAHIC
- Ceva
- Dechra Veterinary Products
- Elanco
- Jindun
- Norbrook
- Ouro Fino Saude
- Vetoquinol
- Virbac
- Wuhan chopperlvya
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pet Intestinal Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pet Intestinal Medicine Sales Estimates and Forecasts (2021-2032)
- 1.3 Pet Intestinal Medicine Market by Type
- 1.3.1 Powder
- 1.3.2 Liquid
- 1.4 Global Pet Intestinal Medicine Market Size by Type
- 1.4.1 Global Pet Intestinal Medicine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pet Intestinal Medicine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pet Intestinal Medicine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pet Intestinal Medicine Industry Trends
- 2.2 Pet Intestinal Medicine Industry Drivers
- 2.3 Pet Intestinal Medicine Industry Opportunities and Challenges
- 2.4 Pet Intestinal Medicine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pet Intestinal Medicine Revenue (2021-2026)
- 3.2 Global Top Players by Pet Intestinal Medicine Sales (2021-2026)
- 3.3 Global Top Players by Pet Intestinal Medicine Price (2021-2026)
- 3.4 Global Pet Intestinal Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Intestinal Medicine Major Company Production Sites & Headquarters
- 3.6 Global Pet Intestinal Medicine Company, Product Type & Application
- 3.7 Global Pet Intestinal Medicine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Intestinal Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Intestinal Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Intestinal Medicine Tier 1, Tier 2, and Tier 3
4 Pet Intestinal Medicine Regional Status and Outlook
- 4.1 Global Pet Intestinal Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pet Intestinal Medicine Historic Market Size by Region
- 4.2.1 Global Pet Intestinal Medicine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pet Intestinal Medicine Sales in Value by Region (2021-2026)
- 4.2.3 Global Pet Intestinal Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pet Intestinal Medicine Forecasted Market Size by Region
- 4.3.1 Global Pet Intestinal Medicine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pet Intestinal Medicine Sales in Value by Region (2027-2032)
- 4.3.3 Global Pet Intestinal Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Intestinal Medicine by Application
- 5.1 Pet Intestinal Medicine Market by Application
- 5.1.1 Reptile
- 5.1.2 Cat
- 5.1.3 Dog
- 5.1.4 Other
- 5.2 Global Pet Intestinal Medicine Market Size by Application
- 5.2.1 Global Pet Intestinal Medicine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pet Intestinal Medicine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pet Intestinal Medicine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 CAHIC
- 6.2.1 CAHIC Company Information
- 6.2.2 CAHIC Business Overview
- 6.2.3 CAHIC Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 CAHIC Pet Intestinal Medicine Product Portfolio
- 6.2.5 CAHIC Recent Developments
- 6.3 Ceva
- 6.3.1 Ceva Company Information
- 6.3.2 Ceva Business Overview
- 6.3.3 Ceva Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Ceva Pet Intestinal Medicine Product Portfolio
- 6.3.5 Ceva Recent Developments
- 6.4 Dechra Veterinary Products
- 6.4.1 Dechra Veterinary Products Company Information
- 6.4.2 Dechra Veterinary Products Business Overview
- 6.4.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
- 6.4.5 Dechra Veterinary Products Recent Developments
- 6.5 Elanco
- 6.5.1 Elanco Company Information
- 6.5.2 Elanco Business Overview
- 6.5.3 Elanco Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Elanco Pet Intestinal Medicine Product Portfolio
- 6.5.5 Elanco Recent Developments
- 6.6 Jindun
- 6.6.1 Jindun Company Information
- 6.6.2 Jindun Business Overview
- 6.6.3 Jindun Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Jindun Pet Intestinal Medicine Product Portfolio
- 6.6.5 Jindun Recent Developments
- 6.7 Norbrook
- 6.7.1 Norbrook Company Information
- 6.7.2 Norbrook Business Overview
- 6.7.3 Norbrook Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Norbrook Pet Intestinal Medicine Product Portfolio
- 6.7.5 Norbrook Recent Developments
- 6.8 Ouro Fino Saude
- 6.8.1 Ouro Fino Saude Company Information
- 6.8.2 Ouro Fino Saude Business Overview
- 6.8.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
- 6.8.5 Ouro Fino Saude Recent Developments
- 6.9 Vetoquinol
- 6.9.1 Vetoquinol Company Information
- 6.9.2 Vetoquinol Business Overview
- 6.9.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
- 6.9.5 Vetoquinol Recent Developments
- 6.10 Virbac
- 6.10.1 Virbac Company Information
- 6.10.2 Virbac Business Overview
- 6.10.3 Virbac Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Virbac Pet Intestinal Medicine Product Portfolio
- 6.10.5 Virbac Recent Developments
- 6.11 Wuhan chopperlvya
- 6.11.1 Wuhan chopperlvya Company Information
- 6.11.2 Wuhan chopperlvya Business Overview
- 6.11.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
- 6.11.5 Wuhan chopperlvya Recent Developments
- 6.12 Merck
- 6.12.1 Merck Company Information
- 6.12.2 Merck Business Overview
- 6.12.3 Merck Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Merck Pet Intestinal Medicine Product Portfolio
- 6.12.5 Merck Recent Developments
- 6.13 Zoetis
- 6.13.1 Zoetis Company Information
- 6.13.2 Zoetis Business Overview
- 6.13.3 Zoetis Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Zoetis Pet Intestinal Medicine Product Portfolio
- 6.13.5 Zoetis Recent Developments
7 North America by Country
- 7.1 North America Pet Intestinal Medicine Sales by Country
- 7.1.1 North America Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pet Intestinal Medicine Sales by Country (2021-2026)
- 7.1.3 North America Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
- 7.2 North America Pet Intestinal Medicine Market Size by Country
- 7.2.1 North America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pet Intestinal Medicine Market Size by Country (2021-2026)
- 7.2.3 North America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pet Intestinal Medicine Sales by Country
- 8.1.1 Europe Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pet Intestinal Medicine Sales by Country (2021-2026)
- 8.1.3 Europe Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
- 8.2 Europe Pet Intestinal Medicine Market Size by Country
- 8.2.1 Europe Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pet Intestinal Medicine Market Size by Country (2021-2026)
- 8.2.3 Europe Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pet Intestinal Medicine Sales by Country
- 9.1.1 Asia-Pacific Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pet Intestinal Medicine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pet Intestinal Medicine Market Size by Country
- 9.2.1 Asia-Pacific Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pet Intestinal Medicine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pet Intestinal Medicine Sales by Country
- 10.1.1 South America Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pet Intestinal Medicine Sales by Country (2021-2026)
- 10.1.3 South America Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
- 10.2 South America Pet Intestinal Medicine Market Size by Country
- 10.2.1 South America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pet Intestinal Medicine Market Size by Country (2021-2026)
- 10.2.3 South America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pet Intestinal Medicine Sales by Country
- 11.1.1 Middle East and Africa Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pet Intestinal Medicine Market Size by Country
- 11.2.1 Middle East and Africa Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pet Intestinal Medicine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pet Intestinal Medicine Value Chain Analysis
- 12.1.1 Pet Intestinal Medicine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pet Intestinal Medicine Production Mode & Process
- 12.2 Pet Intestinal Medicine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pet Intestinal Medicine Distributors
- 12.2.3 Pet Intestinal Medicine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst